Results 141 to 150 of about 41,952 (292)

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; Spring 2020

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; January 2022

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Interview with Ruth Erline Mathis Martin - OH 328

open access: yes, 1984
In her June 1984 interview with Michael Cooke, Ruth Erline Mathis Martin (1934-2020) discussed her time as a DHEC employee in the sickle cell anemia program.
Martin, Ruth Erline Mathis   +1 more
core  

Predicting elevated transcranial doppler velocity among patients with sickle cell anemia in Uganda: A cross-sectional study. [PDF]

open access: yesPLoS One
Nayiga D   +16 more
europepmc   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; Fall 2019

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Hepatic Enzyme Abnormalities and Their Association With Hematological Parameters in Sickle Cell Disease: A Case‐Control Study in Cameroon

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims The polymerization of deoxygenated hemoglobin S, resulting from a genetic mutation in sickle cell disease (SCD), leads to damage in multiple organs, including renal, cardiopulmonary, and cerebrovascular systems. The liver is also commonly affected, resulting in “sickle cell liver disease,” which may lead to progressive ...
Josué Louokdom Simo   +6 more
wiley   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; Summer 2020

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Hydroxyurea Use Among Medicaid Beneficiaries with Sickle Cell Disease in California and Georgia, 2006\u20132016 [PDF]

open access: yes
During 2006\u20132016, the use of hydroxyurea (HU) among Medicaid beneficiaries with sickle cell disease (SCD) who lived in California or Georgia increased. However, many beneficiaries with severe complications of SCD do not use HU.HU was approved by the

core  

Home - About - Disclaimer - Privacy